NCPE Recommends Cost Reduction for Friedreich's Ataxia Drug

The National Centre for Pharmacoeconomics (NCPE) has stated that the cost of a drug for Friedreich's Ataxia must be reduced for the HSE to consider purchasing it.

12 Aug, 09:15 — 12 Aug, 09:15

Post Share

Sources

Showing 1 of 1 sources

rte-newsMostly Factual1d ago

Cost cut needed to cover Friedreich's Ataxia drug - NCPE

There would have to be "significant price reduction" in the cost of a drug to treat Friedreich's Ataxia for it to be covered by the HSE, according to the National Centre for Pharmacoeconomics (NCPE).

Read full article →

PERSPECTA

PERSPECTA

NCPE Recommends Cost Reduction for Friedreich's Ataxia Drug

Sources

Cost cut needed to cover Friedreich's Ataxia drug - NCPE

Related Stories

Health Concerns Raised About Packaged Salads and Visceral Fat

Thousands Report Vision Problems After Viewing Solar Eclipse Without Protection

Austria Reports 97 Percent Occupancy for Public Health Doctor Positions

Hope Fades for Survivors After Devastating Colombia Earthquake

PERSPECTA